• Ownership

James Paul Kastenmayer - Insider Trading & Ownership

Entity
Individual
Location
One Medimmune Way, Floor One, Area Two, Gaithersburg, MD
Summary
The estimated net worth of James Paul Kastenmayer is at least $2.24K dollars as of February 14, 2025. James Paul Kastenmayer is the General Counsel of Aeglea BioTherapeutics, Inc. and owns shares of Spyre Therapeutics, Inc. (SYRE) stock worth about $2.24K.
All Insider Reports
All Insider Reports

Ownership of James Paul Kastenmayer

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
SYRE Spyre Therapeutics, Inc. General Counsel $2.24K Feb 23, 2023
AVBP ArriVent BioPharma, Inc. General Counsel Feb 3, 2025

Insider Transactions Reported by James Paul Kastenmayer:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.